EDAP TMS S.A.

EDAP | NASDAQ | 0 Followers
$1.67 +1.21% $0.02
Follow
Loading...

Profile

EDAP TMS S.A. is an international company based in France specializing in the development and manufacture of medical devices for non-invasive treatment of urological diseases, particularly for prostate diseases. Their main product is the HIFU (High Intensity Focused Ultrasound) technology, which allows for the treatment of benign prostatic hyperplasia (BPH) and prostate cancer without surgery. This technology uses concentrated ultrasound energy to target and destroy tumor or hyperplastic cells without damaging surrounding tissues. EDAP TMS S.A. focuses on providing state-of-the-art medical devices and innovative therapeutic solutions that offer patients safe and effective treatment options for urological diseases.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade